358 related articles for article (PubMed ID: 15064337)
61. Bleeding complications associated with the use of rt-PA versus r-PA for peripheral arterial and venous thromboembolic occlusions.
McNamara TO; Dong P; Chen J; Quinn B; Gomes A; Goodwin S; Aban K
Tech Vasc Interv Radiol; 2001 Jun; 4(2):92-8. PubMed ID: 11981794
[TBL] [Abstract][Full Text] [Related]
62. Results of the RAPID 1 and RAPID 2 thrombolytic trials in acute myocardial infarction.
Weaver WD
Eur Heart J; 1996 Sep; 17 Suppl E():14-20. PubMed ID: 11823998
[TBL] [Abstract][Full Text] [Related]
63. A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial.
Ross AM; Gao R; Coyne KS; Chen J; Yao K; Yang Y; Qin X; Qiao S; Yao M;
Am Heart J; 2001 Aug; 142(2):244-7. PubMed ID: 11479462
[TBL] [Abstract][Full Text] [Related]
64. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.
Ouriel K; Veith FJ; Sasahara AA
N Engl J Med; 1998 Apr; 338(16):1105-11. PubMed ID: 9545358
[TBL] [Abstract][Full Text] [Related]
65. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics.
Lancet; 1995 Aug; 346(8971):329-36. PubMed ID: 7623530
[TBL] [Abstract][Full Text] [Related]
66. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.
del Zoppo GJ; Higashida RT; Furlan AJ; Pessin MS; Rowley HA; Gent M
Stroke; 1998 Jan; 29(1):4-11. PubMed ID: 9445320
[TBL] [Abstract][Full Text] [Related]
67. Reteplase with or without abciximab for peripheral arterial occlusions: efficacy and adverse events.
Hull JE; Hull MK; Urso JA
J Vasc Interv Radiol; 2004 Jun; 15(6):557-64. PubMed ID: 15178715
[TBL] [Abstract][Full Text] [Related]
68. Catheter-directed lysis of iliofemoral vein thrombosis with use of rt-PA.
Verhaeghe R; Stockx L; Lacroix H; Vermylen J; Baert AL
Eur Radiol; 1997; 7(7):996-1001. PubMed ID: 9265661
[TBL] [Abstract][Full Text] [Related]
69. Initial results of reteplase in the treatment of acute lower extremity arterial occlusions.
Davidian MM; Powell A; Benenati JF; Katzen BT; Becker GJ; Zemel G
J Vasc Interv Radiol; 2000 Mar; 11(3):289-94. PubMed ID: 10735421
[TBL] [Abstract][Full Text] [Related]
70. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy.
Bjarnason H; Kruse JR; Asinger DA; Nazarian GK; Dietz CA; Caldwell MD; Key NS; Hirsch AT; Hunter DW
J Vasc Interv Radiol; 1997; 8(3):405-18. PubMed ID: 9152914
[TBL] [Abstract][Full Text] [Related]
71. Comparison of double bolus urokinase versus front-loaded alteplase regimen for acute myocardial infarction. Thrombolysis in Myocardial Infarction in Korea (TIMIKO) study group.
Park SJ
Am J Cardiol; 1998 Sep; 82(6):811-3, A10. PubMed ID: 9761098
[TBL] [Abstract][Full Text] [Related]
72. [Cost-benefit study of different thrombolytic strategies in treating 156 patients with symptomatic pulmonary thromboembolism].
Li XS; Deng XY; Liu HL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jun; 24(6):355-6. PubMed ID: 22681664
[TBL] [Abstract][Full Text] [Related]
73. Transhepatic catheter-directed thrombectomy and thrombolysis of acute superior mesenteric venous thrombosis.
Kim HS; Patra A; Khan J; Arepally A; Streiff MB
J Vasc Interv Radiol; 2005 Dec; 16(12):1685-91. PubMed ID: 16371536
[TBL] [Abstract][Full Text] [Related]
74. Selective thrombolysis in acute deep vein thrombosis: evaluation of adjuvant therapy in vivo.
Roy S; Brosstad F; Sakariassen KS
Cardiovasc Intervent Radiol; 1999; 22(5):403-10. PubMed ID: 10501893
[TBL] [Abstract][Full Text] [Related]
75. Catheter-directed thrombolytic therapy in peripheral artery occlusions: combining reteplase and abciximab.
Drescher P; McGuckin J; Rilling WS; Crain MR
AJR Am J Roentgenol; 2003 May; 180(5):1385-91. PubMed ID: 12704056
[TBL] [Abstract][Full Text] [Related]
76. Comparison of alteplase and urokinase for pharmacomechanical thrombolysis of clotted hemodialysis access.
Tan RY; Pang SC; Teh SP; Lee KG; Chong TT; Gogna A; Tan CS
J Vasc Access; 2019 Sep; 20(5):501-506. PubMed ID: 30585114
[TBL] [Abstract][Full Text] [Related]
77. Catheter-directed thrombolysis with argatroban and tPA for massive iliac and femoropopliteal vein thrombosis.
Sharifi M; Bay C; Nowroozi S; Bentz S; Valeros G; Memari S
Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1586-1590. PubMed ID: 23377239
[TBL] [Abstract][Full Text] [Related]
78. Efficacy and safety of reteplase for central venous catheter occlusion in patients with cancer.
Liu CY; Jain V; Shields AF; Heilbrun LK
J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 1):39-44. PubMed ID: 14709685
[TBL] [Abstract][Full Text] [Related]
79. Feasibility of low-dose infusion of alteplase for unsuccessful thrombolysis with urokinase in deep venous thrombosis.
Gong M; Zhao B; He X; Gu J; Chen G
Exp Ther Med; 2019 Nov; 18(5):3667-3674. PubMed ID: 31602245
[TBL] [Abstract][Full Text] [Related]
80. Single-session endovascular treatment for symptomatic lower extremity deep vein thrombosis: a feasibility study.
Kim BJ; Chung HH; Lee SH; Je BK; Lee YH; Seo BK; Kim BH; Cha SH
Acta Radiol; 2010 Apr; 51(3):248-55. PubMed ID: 20201636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
